Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammation and Blood Brain Barrier Integrity as Biomarkers of Suicidal Behavior
NCT06047613Unknown
- Sponsor
- CHU Montpellier
- Start
- Oct 2023
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Montpellier. Primary endpoint: Blood S100B Level at 1 month. Status: unknown.
Beyond the preview
Go deeper on NCT06047613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06047613.